Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emcure Pharmaceuticals Ltd.

www.emcure.co.in

Latest From Emcure Pharmaceuticals Ltd.

India Coronavirus Actions: Stock Checks, Kaletra Gx Readiness And Bulk Drugs

A string of actions to ensure medicines security and prioritize bulk drug project clearances are underway in India as the country enters a critical phase in its efforts to contain coronavirus cases.

Policy & Regulation Coronavirus COVID-19

Cipla Gears To Step In With Gx Kaletra Supplies For nCoV

Over half a dozen generic versions of AbbVie's Kaletra, currently part of treatment guidelines in China for nCoV-2019, are already on the Indian market and drug maker Cipla says it can make available around 12 million tablets of the combination. India has meanwhile just confirmed its first case of the coronavirus infection.

Generic Drugs Infectious Diseases

India Bars Four Firms On Apixaban

The High Court of Delhi has issued a temporary injunction blocking four Indian drug-makers from launching generic versions of Bristol-Myers’ top-selling anticoagulant apixaban.

Legal Issues Intellectual Property

Vildagliptin Prices Fall By Over 70% In India Post Patent Expiry

Vildagliptin formulation prices fall by over 70% following the expiry of a patent held by Novartis in India. The innovator, meanwhile, is cashing in on co-marketing agreements with Indian partners like USV and Cipla

Commercial Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Emcure Pharmaceuticals Ltd.
  • Senior Management
  • Satish R Mehta, Managing Dir. & CEO
  • Contact Info
  • Emcure Pharmaceuticals Ltd.
    Phone: (91) 20 30610000
    Emcure House, T 184
    Bhosari
    Pune, 411026
    India
UsernamePublicRestriction

Register